Effects of inhaled therapy on biomarkers of systemic inflammation in stable chronic obstructive pulmonary disease. - Wikidata - awgldk - TriplyDB

Effects of inhaled therapy on biomarkers of systemic inflammation in stable chronic obstructive pulmonary disease.

Effects of inhaled therapy on biomarkers of systemic inflammation in stable chronic obstructive pulmonary disease.

http://www.wikidata.org/entity/Q37636173

about

Can the anti-inflammatory activities of β2-agonists be harnessed in the clinical setting?Elevated placenta growth factor predicts pneumonia in patients with chronic obstructive pulmonary disease under inhaled corticosteroids therapy.Surfactant protein D, a clinical biomarker for chronic obstructive pulmonary disease with excellent discriminant values Measuring fatigue as a symptom in COPD: From descriptors and questionnaires to the importance of the problem.Asthma as a disruption in iron homeostasis.DNA damage and cellular abnormalities in tuberculosis, lung cancer and chronic obstructive pulmonary disease.The acute effect of cigarette smoking on the high-sensitivity CRP and fibrinogen biomarkers in chronic obstructive pulmonary disease patients.Current Status of Community-Acquired Pneumonia in Patients with Chronic Obstructive Pulmonary Disease.

P2860

Q28391808-8426CDB6-DD8B-4C7A-B0D8-E46E713EDF91 Q34036358-703D6BE4-CAE2-4FCB-978C-893013298312 Q34676410-7273FACC-A294-4ABD-846A-E65F69557254 Q38370001-06425F67-2093-442B-B6E7-717436149299 Q40551737-149631E2-D218-45CD-9E08-023EDC0F264B Q41808094-CF792C5B-7914-4225-8562-B52E0257E193 Q45898054-6657B78A-9A04-4F98-92F3-BAB45FD7B5B7 Q55031611-6F326212-4555-4A41-850D-464E90AB2146

P2860

Effects of inhaled therapy on biomarkers of systemic inflammation in stable chronic obstructive pulmonary disease.

http://www.wikidata.org/entity/Q37636173

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Effects of inhaled therapy on ...... obstructive pulmonary disease.

@en

Effects of inhaled therapy on ...... obstructive pulmonary disease.

@nl

type

label

Effects of inhaled therapy on ...... obstructive pulmonary disease.

@en

Effects of inhaled therapy on ...... obstructive pulmonary disease.

@nl

prefLabel

Effects of inhaled therapy on ...... obstructive pulmonary disease.

@en

Effects of inhaled therapy on ...... obstructive pulmonary disease.

@nl

P1433

Q37636173-B4AF3EDA-031F-4A3F-A2B6-9055B0A26D72

P1476

Q37636173-53A4C4DB-2357-4928-BB76-53B0C0D17838

P2093

Q37636173-F1B0C9DE-730D-4A92-A87C-4491D8374881

P2860

Q37636173-086CB5E7-E249-4A90-A0EA-1A62E8241FA9

Q37636173-09B42D7B-FCD9-4FF2-91FB-77C4FDA0F780

Q37636173-0FCB9903-2C59-40A1-85B1-74A6A0301136

Q37636173-1C09A976-922B-4A36-A9FB-6F808D49A626

Q37636173-21C219FB-F6E3-4989-A2F4-4FDEE329FE4E

Q37636173-26E861FD-844F-4FE7-9928-F82DEC139052

Q37636173-298A791F-4F80-4DAE-ABAF-F98D9E6726B8

Q37636173-2AF791B6-9921-4A1B-8078-B0E109C85B19

Q37636173-40551D7E-2523-49D8-9126-3E57B59B8625

Q37636173-446EE26C-1176-4523-84F2-90E125CC98CA

P304

Q37636173-4D3D9440-46F4-40CF-9D8A-8D592B561010

P31

Q37636173-4A42B391-972D-48EE-8E07-45E4AEAC6B95

P356

Q37636173-F12919FF-95E6-4813-BCB6-D84AE5963C24

P433

Q37636173-D96867C0-4A71-40CB-BCDE-7E1EBE7ABB5C

P478

Q37636173-46A908B4-158C-4A78-BF9B-20C19D2CA844

P577

Q37636173-E99722D7-1EA8-4BF0-B2E5-2A61A751C322

P698

Q37636173-270EF354-2D20-46BC-BBCD-E22669208DE3

P921

Q37636173-0A3D6F63-9C94-4F87-B716-B94662A55D43

Q37636173-A9658519-95E6-46FB-92F2-3975498B0AE8

Q37636173-F00ED67C-C431-45E8-966E-9C37011F1C54

P356

13547500903311902

P1433

P1476

Effects of inhaled therapy on ...... obstructive pulmonary disease.

@en

P2093

Sabina A Antoniu

http://www.w3.org/2001/XMLSchema#string

P2860

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

C-reactive protein: a critical update

Circulating surfactant protein D as a potential lung-specific biomarker of health outcomes in COPD: a pilot study

Associations of IL6 polymorphisms with lung function decline and COPD.

Alternative mechanisms for long-acting beta(2)-adrenergic agonists in COPD.

Role of TNFalpha in pulmonary pathophysiology.

Long-acting inhaled beta 2-agonists for stable COPD.

Effects of fluticasone propionate on inflammatory cells in COPD: an ultrastructural examination of endobronchial biopsy tissue.

Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis.

P304

97-103

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/13547500903311902

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19929747

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease